Best practice in HRRm testing in patients with metastatic prostate cancer

ASCO 2024: Highlights and analysis

ASCO 2024: Two studies report on isatuximab combos in transplant-ineligible patients with newly diagnosed multiple myeloma

EAU 2024: Bladder cancer latest

Global trends and inequalities in breast cancer survival and care

Multiple myeloma in a resource constrained setting

Remote genetic testing has the potential to increase the uptake of testing in large integrated healthcare systems

Stockholm3 offers a promising avenue for personalised risk-based prostate cancer diagnosis

Novel therapies and combinations in ovarian cancer

Multiple myeloma treatment in Dakar: Epidemiological, diagnostic, and therapeutic aspects

Gastro-intestinal endoscopy capacity in Nigeria: strengths and challenges

Colorectal cancer risk factors in Nigeria